Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 2
1970 2
1972 1
1974 4
1975 1
1978 2
1979 1
1980 3
1981 4
1982 8
1983 3
1984 8
1985 7
1986 10
1987 10
1988 5
1989 9
1990 6
1991 10
1992 8
1993 18
1994 18
1995 14
1996 13
1997 11
1998 8
1999 6
2000 8
2001 13
2002 9
2003 20
2004 11
2005 17
2006 17
2007 18
2008 18
2009 23
2010 20
2011 26
2012 27
2013 13
2014 29
2015 21
2016 26
2017 23
2018 39
2019 27
2020 32
2021 32
2022 19
2023 29
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

677 results

Results by year

Filters applied: . Clear all
Page 1
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG). Ozaka M, et al. Among authors: terashima t. Eur J Cancer. 2023 Mar;181:135-144. doi: 10.1016/j.ejca.2022.12.014. Epub 2022 Dec 27. Eur J Cancer. 2023. PMID: 36652891 Free article. Clinical Trial.
Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis.
Tomomatsu K, Yasuba H, Ishiguro T, Imokawa S, Hara J, Soeda S, Harada N, Tsurikisawa N, Oda N, Katoh S, Numata T, Sugino Y, Yamada M, Kamimura M, Terashima T, Okada N, Tanaka J, Oguma T, Asano K. Tomomatsu K, et al. Among authors: terashima t. Sci Rep. 2023 Apr 4;13(1):5468. doi: 10.1038/s41598-023-32246-8. Sci Rep. 2023. PMID: 37015988 Free PMC article.
Young Talents in Polymer Science.
Besenius P, Schacher FH, Terashima T. Besenius P, et al. Among authors: terashima t. Macromol Rapid Commun. 2021 Apr;42(8):e2100159. doi: 10.1002/marc.202100159. Macromol Rapid Commun. 2021. PMID: 33899993 No abstract available.
Methylmalonic acidemia.
Matsuda I, Terashima T, Yamamoto J, Akaboshi I, Shinozuka S, Hattori S, Nagata N, Oka Y. Matsuda I, et al. Among authors: terashima t. Eur J Pediatr. 1978 Jul 3;128(3):181-6. doi: 10.1007/BF00444303. Eur J Pediatr. 1978. PMID: 27367
[The locoregional therapy for hepatocellular carcinoma].
Yamashita T, Terashima T, Yamashita T. Yamashita T, et al. Among authors: terashima t. Nihon Shokakibyo Gakkai Zasshi. 2023;120(1):35-45. doi: 10.11405/nisshoshi.120.35. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 36631114 Japanese. No abstract available.
Developmental anatomy of reeler mutant mouse.
Katsuyama Y, Terashima T. Katsuyama Y, et al. Among authors: terashima t. Dev Growth Differ. 2009 Apr;51(3):271-86. doi: 10.1111/j.1440-169X.2009.01102.x. Dev Growth Differ. 2009. PMID: 19379278 Review.
677 results